Pupillometric Evaluation in Patients Declared Brain Dead - a Prospective Quality Control Study
NCT ID: NCT06279975
Last Updated: 2025-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2023-12-18
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Performance Evaluation of Pupillary Reactivity in Monitoring of Brain-damaged Patients in Intensive Care
NCT01796886
Insights From the Retina on Cerebral Microvascular Dysfunction in Haemorrhagic Stroke
NCT04363619
Pupillometry in Horner's Syndrome
NCT02978079
Alterations of Conjunctival Microcirculation in Brain Dead Patients
NCT02483273
Photographic Imaging of the Retina and Optic Nerve Head of Glaucoma Patients and Normal Controls
NCT00430274
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
non-invasive device-supported, automated pupillometry
non-invasive device-supported, automated pupillometry with a precise quantitative measurement of the pupils within the range of micrometers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Brain death diagnostic procedures planned
* Treated at the intensive care unit at the University Hospital Basel (USB)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raoul Sutter, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Intensive care unit at the University Hospital Basel
Basel, Canton of Basel-City, Switzerland
University Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Req-2023-01275; am23Sutter2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.